Directive 2001/83/EC of the European Parliament and of the… Article 101

Article 101

The Member States shall take all appropriate measures to encourage doctors and other health care professionals to report suspected adverse reactions to the competent authorities. The Member States may impose specific requirements on doctors and other health care professionals, in respect of the reporting of suspected serious or unexpected adverse reactions, in particular where such reporting is a condition of the marketing authorization.

Read the full instrument → · Read this in context: TITLE IX — PHARMACOVIGILANCE →

Other provisions in TITLE IX — PHARMACOVIGILANCE

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 101 of Directive 2001/83/EC of the European Parliament and of the… (LawPlayer, data as of 2026-07-04)

What to look at next

Directive 2001/83/EC of the European Parliament and of the…, full textChapter navigation and full text, so you can read this section in contextEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year TITLE IX — PHARMACOVIGILANCE — read this in contextThe surrounding text of the act in order, so you can see what comes before and afterChapters and sections